What is Aviv Scientific?
Aviv Scientific operates at the intersection of advanced medical science and personalized wellness, focusing on the mitigation of age-related cognitive and physical decline. The company utilizes a multi-modal therapeutic framework, most notably hyperbaric oxygen therapy, integrated with cognitive training and nutritional guidance. Their clinical methodology is designed to address complex conditions, including post-stroke recovery and long COVID, while maintaining rigorous standards set by the Undersea and Hyperbaric Medical Society. By prioritizing data-driven outcomes, Aviv Scientific has established a unique market position as a leader in the longevity sector, catering to an aging demographic that demands high-efficacy, science-backed health solutions.
How much funding has Aviv Scientific raised?
Aviv Scientific has raised a total of $40M across 1 funding round:
Series B
$40M
Series B (2021): $40M with participation from Deep-Insight and Danel FC Financial Solutions
Key Investors in Aviv Scientific
Deep-Insight
A consultancy firm specializing in B2B customer experience and employee engagement, providing actionable insights to drive strategic business growth.
Danel FC Financial Solutions
A financial services provider focused on delivering comprehensive fiscal solutions and strategic capital management for growing enterprises.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Aviv Scientific?
With the recent capital secured, Aviv Scientific is expected to prioritize the expansion of its clinical infrastructure and the further validation of its therapeutic protocols. The strategic roadmap likely includes scaling its service delivery model to reach a wider international audience while investing in longitudinal research to solidify its clinical authority. As the company navigates this growth phase, the focus will remain on enhancing patient outcomes through technological integration and the refinement of its personalized care programs. This trajectory suggests a long-term commitment to dominating the niche of cognitive and physical optimization, potentially setting new benchmarks for the longevity industry.
See full Aviv Scientific company page
